CareTrust REIT Inc. (CTRE)

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

• Sales growth 10Y > 5% 18.4%
• Exp. sales growth 3Y > 5% 20.3%
• EBIT growth 10Y > 5% 22.3%
• Exp. EBIT growth 3Y > 5% 5.3%
• Net debt < 4x EBIT 2.2x
• EBIT positive, 10Y straight 10
• Max. EBIT decline < 50% 0.6%
• Return on equity > 15% 8.0%
• ROCE > 15% 6.5%
• Expected return > 10% 9.5%

View all AAQS quality stocks · Read the methodology at AlleAktien

Source: fundamental data

In den letzten 4 Quartalsberichten und 2 Jahresberichten von CareTrust REIT findet sich kein wesentlicher KI-Bezug — als Bestandshalter von Pflege- und Senioren-Immobilien erwähnt das Unternehmen „artificial intelligence“ nur zweimal im 10-K 2026, beide Male als generische Cybersecurity-Floskel: einmal als Werkzeug immer raffinierterer Angriffe („…attacks and intrusions from around the world have increased, including through the use of evolving technologies such as artificial intelligence“), einmal als möglicher Auslöser von IT-Vorfällen bei Mietern/Betreibern („…including from their adoption or use of artificial intelligence, if applicable“). Weder KI-Umsatzquelle noch operativer KI-Einsatz noch ein konkretes, aufs eigene Geschäftsmodell bezogenes KI-Risiko; in den vier 10-Q und im 10-K 2025 gar keine Treffer.

Between 2023-Q4 and 2026-Q1, CareTrust REIT met or beat its own full-year guidance every single year and grew annual investment volume from 288 million dollars (2023) to 1.8 billion dollars (2025). Re-checking the ten transcripts shows that no datable commitment made on these calls can be shown to have been broken. The sharpest-looking points dissolve on a close read. The decline in going-in yields is explained by the move into the UK and seniors housing, the doubling of general and administrative cost by the UK acquisition, the SHOP team build-out and incentive accruals, and the never-reached leverage target is explicitly a long-term range that the company undershoots. One point stays open: on its large tenant PACS, management gave the all-clear in 2024-Q4, then twice pointed to the tenant's own pending filings, and later never returned to the topic. The all-clear itself held up.

10 calls reviewed, 2023-Q4 through 2026-Q1 · As of August 2, 2026

Management promises

• 2023-Q4 kept

  The sale of the 11-facility Midwest skilled nursing portfolio with negative earnings would get done; the buyer was said to be making continued good-faith efforts.

  The portfolio was sold in the third quarter of 2024 (2024-Q3). Management never set a date of its own; the one to two months mentioned in 2024-Q1 were expressly relayed as the buyer's own estimate.

• 2024-Q2 open

  The ongoing operator transitions and sales were to deal with every property that had underpaid that year; on timing Sedgwick said he was hesitant to predict but hopeful the work would be done by the end of 2024.

  The Midwest portfolio was sold in the third quarter of 2024, and later calls no longer name a residual list of underpaying properties. Whether every individual case was closed by year end is not evident from the transcripts; no missed deadline can be established from them, especially as the statement was explicitly framed as a hope.

• 2024-Q3 kept

  The Tennessee portfolio of 31 skilled nursing facilities for roughly 500 million dollars (CareTrust share about 442 million) would close in two tranches in December 2024.

  The bulk closed in December 2024 as announced; the final facility only followed after the turn of the year (2024-Q4). Kept in substance, although the facility count was stated differently across the two calls.

• 2024-Q4 kept

  Normalized FFO per share of 1.68 to 1.72 dollars for fiscal 2025, assuming no further investments.

  The company delivered 1.76 dollars (2025-Q4), above the opening guidance. The range was raised to 1.77 to 1.79 in between (2025-Q2) and pulled back to 1.76 to 1.77 in 2025-Q3, explained by the timing gap between the equity raise and closings.

• 2025-Q2 kept

  CEO Sedgwick said he would be very surprised if the company did not get a first seniors housing operating (SHOP) deal done within twelve months.

  The first SHOP deal (three communities in Texas) closed already in the fourth quarter of 2025 (2025-Q4), with a second following in May 2026 (2026-Q1). Delivered faster than promised.

• 2025-Q2 open

  The takeover of the UK external manager was to produce savings of roughly 5 million dollars, about half of that manager's 10 million dollar run rate, kicking in mostly from the first quarter of 2026.

  The figure was never picked up again in the 2025-Q3, 2025-Q4 or 2026-Q1 calls, and no analyst followed up. Whether the savings materialized cannot be verified from the transcripts.

Based on public earnings call transcripts. Reviewed: 10 transcripts 2023-Q4 through 2026-Q1.

Ten checks against the annual reports — each one passed counts a point.

• Revenue grows by more than 15% a year over three years 36.5% passed
• More than 10% revenue growth is expected for the coming year 17.3% passed
• Share count grows by less than 3% a year 28.3% failed
• Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 188.3% passed
• Gross margin at 40% or higher and without meaningful erosion 59.1% failed
• Goodwill from acquisitions does not grow faster than revenue 0.0% passed
• Net debt below twice EBITDA 1.5 x EBITDA passed
• Operating cash flow covers the profits of the last three years 294 m passed
• Return on capital at 15% or higher, or up versus two years ago 6.5% passed
• Insiders hold at least 10% or are net buyers 0.8% failed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail